Additionally, programmed death-1 ligand-1 (PD-L1) expressed by the tumor cells or the tumor microenvironment inhibits CAR-T cell cytotoxicity in B cell malignancies and have been associated with poor immunotherapy success.92 The gene discussed is CD274; the disease is neoplasm.